Nexgel (NXGLW) Cash & Current Investments (2019 - 2025)
Nexgel's (NXGLW) quarterly Cash & Current Investments came in at $1.8 million in Q4 2025, little changed YoY from $1.8 million in Q4 2024, and down 3.18% on a QoQ basis from $1.9 million in Q3 2025.
Nexgel (NXGLW) Cash & Current Investments (2019 - 2025) Analysis & Trends
Nexgel (NXGLW) has 7 years of Cash & Current Investments data on file, last reported at $1.8 million in Q4 2025.
- Quarterly Cash & Current Investments changed 0.44% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (changed 0.44% YoY) and the FY2025 annual result came in at $1.8 million, changed 0.44% from the prior year.
- Cash & Current Investments declined to $1.8 million in Q4 2025, from $1.9 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $13.4 million in Q4 2021 to a low of $382000.0 in Q2 2021.
- A 5-year average of $3.9 million and a median of $2.1 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2021 — Cash & Current Investments soared 41618.75% — and 2024, when it slumped 75.16%.
- Tracing NXGLW's Cash & Current Investments over 5 years: stood at $13.4 million in 2021, then plunged by 50.49% to $6.6 million in 2022, then sank by 59.15% to $2.7 million in 2023, then slumped by 33.07% to $1.8 million in 2024, then dropped by 0.44% to $1.8 million in 2025.
- The last three Cash & Current Investments figures came in at $1.8 million (Q4 2025), $1.9 million (Q3 2025), and $725000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 863.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.68 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | 1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 725,000.00 |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 2.42 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 4.30 Mn |
| Mar 31, 2023 | 5.79 Mn |
| Dec 31, 2022 | 6.61 Mn |
| Sep 30, 2022 | 7.43 Mn |
| Jun 30, 2022 | 9.82 Mn |
| Mar 31, 2022 | 10.52 Mn |
| Dec 31, 2021 | 13.35 Mn |
| Sep 30, 2021 | 1.26 Mn |
| Jun 30, 2021 | 382,000.00 |
| Mar 31, 2021 | 1.07 Mn |